EichorEICHOR
Location: Wuhu Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Wuhu

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Wannan Medical College Yijishan Hospital · Pfizer · NCT07028853
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA · The First Affiliated Hospital of Wannan Medical College · Jinling Hospital, China · NCT06118840
Pleural Strain by Speckle-Tracking Ultrasound: Feasibility and Driving Pressure Associations
Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT06911450
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
Phase N/A · The First Affiliated Hospital of Shihezi University · First Affiliated Hospital of Wannan Medical College · NCT06963489
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The First Affiliated Hospital of Wannan Medical College · Shanghai Henlius Biotech · NCT07160335
The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
Phase N/A · Department of Urology, The First Affiliated Hospital of Wann · Anhui Provincial Hospital · NCT06737588
The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Larg
NA · The first affiliated hospital of Wannan Medical College · yilong Wang · NCT06374667
Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension
Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT07033260
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
NA · The First Affiliated Hospital, Yijishan Hospital of Wannan M · First Affiliated Hospital of Wannan Medical College · NCT06143488
China HeadAche DIsorders RegiStry
Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · Beijing Tiantan Hospital · NCT05334927
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · The First Affiliated Hospital Of Wannan Medical College · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Wannan Medical College Yijishan Hospital · Pfizer · NCT06629779
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Phase 3 · The Second Affiliated Hospital of Wannan Medical College · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06842199
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Wannan Medical College Yijishan Hospital · Eli Lilly and Company · NCT06119581
Safety and Efficacy of Ventricular Irrigation for Ventriculitis
NA · The First Affiliated Hospital of Wannan Medical College · RenJi Hospital · NCT06358209
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Phase 2 · The Second Affiliated Hospital of Wannan Medical College · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07236099
ICP-332 in Subjects With Non-segmental Vitiligo
Phase 2/Phase 3 · The First Affiliated Hospital of Wannan Medical College · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07047612
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
Phase 2 · Wuhu Hospital Affiliated to East China Normal University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06452706
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2)
Phase 3 · The First Affiliated Hospital of Wannan Medical University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07043725
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Smal
Phase 3 · The First Affiliated Hospital of Wannan Medical College · RemeGen Co., Ltd. · NCT07416474
A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
Phase 3 · Research Site · AstraZeneca · NCT06471257
POASAC Study (Preoperative Anemia Severity and Classification Study)
Phase N/A · Department of Anesthesiology, First Affiliated Hospital of W · Peking Union Medical College Hospital · NCT06499974
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
Phase 3 · Research Site · AstraZeneca · NCT07520162
Focused Ultrasound Spleen Stimulation and Inflammation in Septic Shock
NA · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT06990295
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
Phase 3 · Yijishan Hospital of Wannan Medical College · Takeda · NCT05837897
Inferior Vena Cava Collapsibility Index and Intradialytic Hypotension
Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT07033273
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Phase 3 · The First Affiliated Hospital of Wannan Medical College · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06900920
A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
Phase 3 · Investigator Site 03 · Waterstone Pharmaceutical (Wuhan) Co., LTD. · NCT07251309
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Phase 3 · The Second Affiliated Hospital of Wannan Medical College · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06775860
Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis
Phase N/A · The First Affiliated Hospital of Wannan Medical College (Yij · First Affiliated Hospital of Wannan Medical College · NCT07022847
Look up another city
Look up another condition